Jennifer Chao
Director/Board Member en ENDO INTERNATIONAL PLC .
Fortuna: 10 $ al 31/03/2024
Perfil
Jennifer M.
Chao is the founder and the Managing Partner of Corestrategies Management LLC, which was founded in 2008.
She is currently serving as an Independent Director at Endo International Plc and Cardiol Therapeutics, Inc. She is also a Director at Endo Pharmaceuticals, Inc. Ms. Chao previously served as the Chairman of BioSpecifics Technologies Corp.
from 2019 to 2020.
She has also held positions as a Managing Director at RBC Capital Markets, Inc., an Independent Director at Edesa Biotech, Inc. from 2022 to 2023, a Research Analyst at Deutsche Bank Securities, Inc., and a Vice President at Leerink Swann & Co. Ms. Chao obtained her undergraduate degree from New York University in 1992.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ENDO INTERNATIONAL PLC
0.01% | 12/04/2023 | 24 921 ( 0.01% ) | 10 $ | 31/03/2024 |
| 29/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Jennifer Chao
| Empresas | Cargo | Inicio |
|---|---|---|
| ENDO INTERNATIONAL PLC | Director/Board Member | 17/02/2021 |
| CARDIOL THERAPEUTICS INC. | Director/Board Member | 15/03/2022 |
| Corestrategies Management LLC | Founder | 01/01/2008 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Director/Board Member | - |
Antiguos cargos conocidos de Jennifer Chao.
| Empresas | Cargo | Fin |
|---|---|---|
| EDESA BIOTECH, INC. | Director/Board Member | 01/06/2023 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Chairman | 02/12/2020 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Analyst-Equity | 29/02/2008 |
| Leerink Swann & Co. | Corporate Officer/Principal | - |
RBC Capital Markets, Inc.
 RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Corporate Officer/Principal | - |
Formación de Jennifer Chao.
| New York University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| ENDO INTERNATIONAL PLC | Health Technology |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| EDESA BIOTECH, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
RBC Capital Markets, Inc.
RBC Capital Markets, Inc. Investment ManagersFinance Part of Royal Bank of Canada, RBC Capital Markets, Inc. provides investment advice. The private company is based in Albany, NY. | Finance |
| Leerink Swann & Co. | Finance |
| Corestrategies Management LLC |
- Bolsa de valores
- Insiders
- Jennifer Chao
